HeiLongJiang ZBD Pharmaceutical Co., Ltd.SSE: 603567

(603567)"Heilongjiang ZBD Pharmaceutical Co., Ltd."Report for Q3 2026

· Issued by HeiLongJiang ZBD Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 603567 · · 13 pages · Chinese

Summary by 6ix AI

The report indicates a substantial decrease in revenue and net profit compared to the same period last year, reflecting challenges in sales performance. The company also reported a notable decline in cash flow from operating activities, attributed to reduced sales collections. The financial statements included in the report have not been audited, and the board assures the accuracy and completeness of the information provided.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

HeiLongJiang ZBD Pharmaceutical Co., Ltd. on 6ix

Earlier from HeiLongJiang ZBD Pharmaceutical

Later from HeiLongJiang ZBD Pharmaceutical

All HeiLongJiang ZBD Pharmaceutical news releases